Trial Profile
Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine; Losartan; Nifedipine
- Indications Essential hypertension; Metabolic syndrome
- Focus Pharmacodynamics
- 15 Aug 2012 New trial record